Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Gschwendtner

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of the American College of Cardiology|July 9, 2013
Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease)Johannes Lammer, Thomas Zeller, Klaus A Hausegger, et al.
Cardiovascular and Interventional Radiology|March 18, 2015
Erratum to: Sustained Benefit at 2 Years for Covered Stents Versus Bare-Metal Stents in Long SFA Lesions: The VIASTAR TrialJohannes Lammer, Thomas Zeller, Klaus A Hausegger, et al.
Cardiovascular and Interventional Radiology|December 5, 2014
Sustained benefit at 2 years for covered stents versus bare-metal stents in long SFA lesions: the VIASTAR trialJohannes Lammer, Thomas Zeller, Klaus A Hausegger, et al.
Wiener Klinische Wochenschrift|September 22, 2011
Austrian Joint ÖGGH-ÖGIR-ÖGHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinomaMarkus Peck-Radosavljevic, Wolfgang Sieghart, Claus Kölblinger, et al.
Cardiovascular and Interventional Radiology|August 22, 2019
The Randomized Freeway Stent Study: Drug-Eluting Balloons Outperform Standard Balloon Angioplasty for Postdilatation of Nitinol Stents in the SFA and PI SegmentJosef Tacke, Stephan Müller-Hülsbeck, Henrik Schröder, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of the American College of Cardiology|July 9, 2013
Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease)Johannes Lammer, Thomas Zeller, Klaus A Hausegger, et al.
Cardiovascular and Interventional Radiology|March 18, 2015
Erratum to: Sustained Benefit at 2 Years for Covered Stents Versus Bare-Metal Stents in Long SFA Lesions: The VIASTAR TrialJohannes Lammer, Thomas Zeller, Klaus A Hausegger, et al.
Cardiovascular and Interventional Radiology|December 5, 2014
Sustained benefit at 2 years for covered stents versus bare-metal stents in long SFA lesions: the VIASTAR trialJohannes Lammer, Thomas Zeller, Klaus A Hausegger, et al.
Wiener Klinische Wochenschrift|September 22, 2011
Austrian Joint ÖGGH-ÖGIR-ÖGHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinomaMarkus Peck-Radosavljevic, Wolfgang Sieghart, Claus Kölblinger, et al.
Cardiovascular and Interventional Radiology|August 22, 2019
The Randomized Freeway Stent Study: Drug-Eluting Balloons Outperform Standard Balloon Angioplasty for Postdilatation of Nitinol Stents in the SFA and PI SegmentJosef Tacke, Stephan Müller-Hülsbeck, Henrik Schröder, et al.
Pageof 2